Rejuvenate Bio utilizes gene therapy to develop treatments aimed at reversing aging and addressing chronic, age-related diseases that affect six in ten Americans. By targeting the underlying genetic factors of these conditions, the company aims to reduce the prevalence and healthcare costs associated with chronic diseases.
Funding
Funding not disclosed
Founders
Product
Problem
Chronic, age-related diseases affect a significant portion of the population, leading to increased healthcare costs and reduced quality of life. These conditions often lack effective treatments that address the underlying causes of aging.
Solution
Rejuvenate Bio is developing gene therapies designed to reverse aging and treat chronic, age-related diseases. By targeting the genetic factors contributing to these conditions, the company aims to develop treatments that can slow down or reverse the aging process, potentially reducing the incidence and severity of age-related diseases. This approach seeks to address the root causes of these diseases rather than just managing their symptoms. The company's therapies are designed to improve overall health and well-being by targeting the fundamental mechanisms of aging.
Target Audience
The primary target audience includes individuals suffering from or at risk of developing chronic, age-related diseases, as well as healthcare providers seeking innovative treatments for these conditions.
Features
- Gene therapy approach targeting the underlying genetic factors of aging
- Development of treatments for chronic, age-related diseases
- Focus on reversing or slowing down the aging process